<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>chemotherapy reproductive toxicity &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/chemotherapy-reproductive-toxicity/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 22 Oct 2025 19:22:36 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>chemotherapy reproductive toxicity &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Flaxseed Lignans Combat Doxorubicin-Induced Ovarian Insufficiency</title>
		<link>https://bioengineer.org/flaxseed-lignans-combat-doxorubicin-induced-ovarian-insufficiency/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 22 Oct 2025 19:22:34 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[chemotherapy reproductive toxicity]]></category>
		<category><![CDATA[doxorubicin-induced ovarian insufficiency]]></category>
		<category><![CDATA[flaxseed lignans]]></category>
		<category><![CDATA[ovarian function preservation]]></category>
		<category><![CDATA[Women's health research]]></category>
		<guid isPermaLink="false">https://bioengineer.org/flaxseed-lignans-combat-doxorubicin-induced-ovarian-insufficiency/</guid>

					<description><![CDATA[In a groundbreaking study set to reshape our understanding of reproductive health, researchers have unveiled significant findings regarding the role of flaxseed lignans in mitigating the adverse effects of chemotherapy on ovarian function. This research specifically addresses the alarming issue of premature ovarian insufficiency (POI) induced by doxorubicin, a widely used chemotherapeutic agent. The vivid [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">285360</post-id>	</item>
	</channel>
</rss>
